News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Combo of Avastin, Second Drug Shows Promise Fighting Brain Cancer, Mayo Clinic Finds

Al's Comment:

 This is an exciting finding.. these researchers have shown that Avastin does make the GBM cells more invasive. (A recent article we posted here said that it doesn't), at least in the test tube.  They also show that adding dasatinib would stop that invasiveness.  They are now about to try it in human trials.  WIll watch this one closely. Best part is that both drugs are available now - Avastin is approved for GBMs and dasatinib is approved for leukemia but can be used off label for anything.


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.mayoclinic.org/news2013-jax/7302.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740